固体器官和血造干细胞移植中的肠道微生物群
J Casper Swarte1, Shuyan Zhang1, Stephan J L Bakker2
1Gastroenterology and Hepatology, University of Groningen and University Medical Centre, Groningen, The Netherlands.
Nature reviews. Microbiology
|January 12, 2026
概括
肠道微生物群通过影响移植功能,感染风险和药物代谢,显著影响移植成功. 针对微生物组提供了一种新的方法来改善移植受体的结果.
科学领域:
- 免疫学 免疫学 免疫学
- 微生物学 微生物学
- 移植科学 移植科学
背景情况:
- 固体器官和干细胞移植改善了末期器官衰竭和血液恶性瘤的结果.
- 长期的移植成功往往受到移植排斥,感染和药物毒性的限制.
研究的目的:
- 探索肠道微生物及其代谢物在调节移植结果中的作用.
- 讨论移植和免疫抑制如何改变肠道生态系统并与临床结果相关.
主要方法:
- 对移植受体肠道微生物组变化的新兴证据的审查.
- 对肠道微生物药物代谢的药物微生物学研究的分析.
- 肠道失调与移植功能,感染风险和患者存活率的相关性.
主要成果:
- 移植接受者经常表现出肠道失调,这与移植功能较差和感染易感性增加有关.
- 肠道微生物可以代谢免疫抑制药物,影响其有效性和安全性.
- 肠道生态系统的变化是由移植和免疫抑制塑造的,影响临床结果.
结论:
- 肠道微生物组是影响移植结果的关键,可修改的因素.
- 微生物组的洞察力可以用于生物标志物或有针对性的干预措施,以提高移植成功.
- 未来的战略应侧重于微生物组调制,以改善固体器官和干细胞移植结果.
相关概念视频
Bone Marrow Sampling and Transplants
862
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
862
Tissue Transplantation
888
Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
888
Cell-mediated Immune Responses
83.4K
Overview
83.4K
Regulation of Hematopoietic Stem Cells
3.9K
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
3.9K


